Cyborg body augmentation
Elective surgical upgrades that make the body partly machine, with implanted eyes that outperform natural ones, wired-in reflexes, built-in weapons and replaceable organs, bought in clinics like any other product.
In shortCyborg body augmentation, from Neuromancer (William Gibson, 1984), is at technology readiness level 1 of 9 (basic principles observed) at its weakest link. Held back by Electronic reflex acceleration. Science status: consistent with known physics; key effects unproven at scale. Estimated new funding to unlock: $5.3B–25B (a floor; some parts are priced only to early research).
Molly's mirrored lenses are surgically inset over her eye sockets, four-centimeter scalpel blades slide out from under her fingernails, and her reflexes are wired; Case gets a new pancreas and liver and his damaged nervous system rebuilt in a Chiba clinic.
Closest todayThe PRIMA subretinal implant restored letter reading to people blinded by macular degeneration (NEJM, 2026); bone-anchored, nerve-controlled bionic arms and legs are used daily by amputees.
Dependency stack
- Wired reflexes that make a street samurai faster than any unmodified human
- Reaction time is dominated by sensory processing and decision-making, which an implant cannot skip without acting for the person
- Reading intent fast and reliably enough to beat natural motor pathways
- Muscles and tendons limit speed even when triggered early
plausibleTRL 1- Reading motor intent at millisecond resolution
✕2 blockers›
- Tissue response degrades signal over years
- Channel count and wireless bandwidth
TRL 6- Channel count is limited by wireless data and power budget
✕3 blockers›
- Tissue heating caps implant power at a few hundred milliwatts, which bounds radio and compute
- Raw broadband neural data exceeds the link, forcing on-implant spike detection and compression
- Battery or wireless-power lifetime versus the decades a permanent interface implies
TRL 5- Implant power density sets what telemetry and on-board compute are affordable
✕2 blockers›
- Cycle life of lithium-metal anodes
- Thermal runaway safety
TRL 6
- criticalImplanted visual prosthesesMolly's lenses replace her eyes and add readouts and low-light vision
✕3 blockers›
- Pixel density and field of view far below the natural retina
- Implants only work while some retinal or cortical circuitry survives
- Encoding color and natural percepts rather than flashes of light
TRL 3- Producing natural-looking percepts rather than phosphenes
✕4 blockers›
- Channel count and spatial resolution; phosphenes are coarse and do not tile a visual field
- Charge-density safety limits cap how often and how strongly tissue can be driven
- Stimulation artifacts blind the recording channels needed for closed-loop control
- No model specifies the pattern for an arbitrary complex percept
TRL 5- Stimulation needs the same dense chronic arrays as recordingTRL 6
- Thousands of stimulation sites to form a detailed imageTRL 6
- Compact actuators to extend and retract implanted mechanisms
✕3 blockers›
- Kilovolt supply electronics and dielectric breakdown risk
- Low force per actuator and limited cycle life versus electric motors
- No integrated sensing comparable to muscle spindles
TRL 4 - Implants that keep working with nerves for decades rather than scarring over
✕3 blockers›
- Micromotion between rigid device and pulsating tissue drives chronic inflammation
- Thin-film encapsulation (polyimide, parylene, SiC) eventually admits water and fails
- Electrode charge-injection limits and corrosion under years of continuous stimulation
TRL 4 - Hardware anchored in bone and driven by the wearer's own nerves, like Molly's retractable blades
✕3 blockers›
- Infection risk where the implant passes through the skin
- Durable implanted electrodes for decades of use
- Natural-feeling touch and position feedback
TRL 7- Quiet, powerful joints the size of natural muscleTRL 4
- Implanted electrodes that keep working for decadesTRL 4
- supportingGene-edited xenograft donor animalsOff-the-shelf replacement organs like Case's new pancreas and liver
✕4 blockers›
- Graft survival measured in months, not years - chronic rejection and thrombotic microangiopathy persist
- Porcine endogenous retrovirus and novel-zoonosis risk requires lifelong recipient surveillance
- Organ growth mismatch and porcine protein incompatibilities (complement, coagulation) are only partly corrected by current edit sets
- Designated-pathogen-free breeding and organ-recovery facilities do not exist at transplant-program scale
TRL 6- Edited cell lines are turned into animals by cloning
✕3 blockers›
- Incomplete epigenetic reprogramming of the donor nucleus produces placental defects and large-offspring syndrome
- Efficiency is a few percent of transferred embryos, so each live birth consumes many donor eggs and surrogates
- Donor egg supply is the limiting input for any primate-scale program
TRL 5 - Even heavily edited organs are rejected without durable tolerance
✕3 blockers›
- Chronic antibody-mediated rejection proceeds even under current immunosuppression
- Tolerance protocols trade rejection risk for conditioning toxicity and graft-versus-host disease
- No assay predicts which recipients can be safely weaned off drugs
TRL 5 - Donor lines need tens of simultaneous edits across rejection, coagulation and retroviral loci
✕3 blockers›
- Structural variants and large deletions accumulate with edit count and are missed by short-read screening
- Edited cell lines lose clonogenic and developmental potency after many rounds of editing
- No method reaches the thousands of edits implied by whole-genome rewriting
TRL 6- Higher-fidelity, smaller editor and recombinase proteins are the route to many simultaneous edits
✕1 blocker›
- Designing catalysis and conformational dynamics
TRL 6
Who could unlock it
- Grégoire CourtineResearcher, EPFLLeads closed-loop spinal cord stimulation that turns decoded intent into walking after paralysis
- ONWARD MedicalCompanyCommercializing spinal cord stimulation therapies developed with EPFL
- Science CorporationStartupAcquired and took the PRIMA subretinal implant through its pivotal trial and regulatory filing
- Daniel PalankerResearcher, Stanford UniversityInvented the photovoltaic subretinal implant technology behind PRIMA
- Christoph KeplingerResearcher, Max Planck Institute for Intelligent SystemsPrincipal inventor of HASEL electrohydraulic artificial muscles; leads the Robotic Materials department
- Artimus RoboticsStartupCU Boulder spinout (2018) commercializing HASEL actuators, funded by NSF SBIR and other grants
- Clone RoboticsStartupUnveiled Protoclone (Feb 2025), a musculoskeletal android driven by 1,000+ hydraulic 'Myofiber' artificial muscles
- Ray BaughmanResearcher, University of Texas at Dallas NanoTech InstitutePioneered twisted and coiled carbon-nanotube and polymer-fiber artificial muscles
- Jia LiuResearcher, Harvard SEASPioneer of tissue-like and syringe-injectable mesh electronics; co-founded Axoft
- AxoftStartupSoft Fleuron polymer probe completed a first-in-human safety study in 2025; raised over $18M
- ParadromicsStartupReported four years of stable preclinical recording in 2026 with platinum-iridium microwires and a titanium hermetic package
- NeuralinkStartupThin polymer thread electrodes implanted in multiple human participants since 2024
- IntegrumCompanyMakes the OPRA bone-anchored implant system for prosthetic limbs
- Max Ortiz CatalanResearcherLed the self-contained neuromusculoskeletal arm prosthesis used daily by amputees
- Hugh HerrAcademic lab, MIT Media Lab Biomechatronics groupDeveloped the agonist-antagonist myoneural interface and the neurally controlled bionic leg
Beyond engineering
- Medical ethics of surgery on healthy bodies for enhancement rather than therapy
- Device makers abandoning implants, leaving users with unsupported hardware in their bodies
- Weapons law for blades and other implanted arms